Dabigatran versus Warfarin for Venous Thromboembolism

被引：0
|
作者：
Peetz, Dirk [1 ]
Lackner, Karl J. [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Mainz, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 362卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1050 / 1050
页数：1
相关论文
共 50 条
  • [1] Dabigatran Etexilate Versus Warfarin in the Treatment of Venous Thromboembolism
    Schulman, Sam
    Eriksson, Henry
    Goldhaber, Samuel Z.
    Kakkar, Ajay K.
    Kearon, Clive
    Mismetti, Patrick
    Schellong, Sebastian M.
    Baanstra, David
    Schnee, Janet
    BLOOD, 2009, 114 (22) : 3 - 3
  • [2] Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
    Schulman, Sam
    Kearon, Clive
    Kakkar, Ajay K.
    Mismetti, Patrick
    Schellong, Sebastian
    Eriksson, Henry
    Baanstra, David
    Schnee, Janet
    Goldhaber, Samuel Z.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24): : 2342 - 2352
  • [3] Bleeding events with dabigatran or warfarin in patients with venous thromboembolism
    Majeed, Ammar
    Goldhaber, Samuel Z.
    Kakkar, Ajay
    Kearon, Clive
    Eriksson, Henry
    Kreuzer, Joerg
    Feuring, Martin
    Hantel, Stephan
    Friedman, Jeffrey
    Schellong, Sebastian
    Schulman, Sam
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 291 - 298
  • [4] Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
    Schulman, Sam
    Goldhaber, Samuel Z.
    Kearon, Clive
    Kakkar, Ajay K.
    Schellong, Sebastian
    Eriksson, Henry
    Hantel, Stefan
    Feuring, Martin
    Kreuzer, Joerg
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (01) : 150 - 157
  • [5] Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
    Schulman, Sam
    Kearon, Clive
    Kakkar, Ajay K.
    Schellong, Sebastian
    Eriksson, Henry
    Baanstra, David
    Kvamme, Anne Mathilde
    Friedman, Jeffrey
    Mismetti, Patrick
    Goldhaber, Samuel Z.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (08): : 709 - 718
  • [6] Dabigatran or warfarin for extended maintenance therapy of venous thromboembolism
    Schulman, S.
    Eriksson, H.
    Goldhaber, S. Z.
    Kakkar, A. K. L.
    Kearon, C.
    Kvamme, A. M.
    Mismetti, P.
    Schellong, S.
    Schnee, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 731 - 732
  • [7] Dabigatran or warfarin in the treatment of acute venous thromboembolism in antiphospholipid syndrome
    Schulman, S.
    Goldhaber, S.
    Kearon, C.
    Kakkar, A. K.
    Schellong, S.
    Eriksson, H.
    Schueler, E.
    Feuring, M.
    Kreutzer, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 985 - 985
  • [8] Direct Thrombin Inhibitors for the Treatment of Venous Thromboembolism: Analysis of the Dabigatran versus Warfarin Clinical Trial
    Liem, Timothy K.
    DeLoughery, Thomas G.
    SEMINARS IN VASCULAR SURGERY, 2011, 24 (03) : 157 - 161
  • [9] Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
    Schulman, Sam
    Kakkar, Ajay K.
    Goldhaber, Samuel Z.
    Schellong, Sebastian
    Eriksson, Henry
    Mismetti, Patrick
    Christiansen, Anita Vedel
    Friedman, Jeffrey
    Le Maulf, Florence
    Peter, Nuala
    Kearon, Clive
    CIRCULATION, 2014, 129 (07) : 764 - 772
  • [10] Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial)
    Prandoni, Paolo
    Taher, Ali
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (06) : 1035 - 1037
12345